New drug aims to regrow hair in alopecia patients
Disease control
Recruiting now
This early-stage study tests a new drug called HCW9302 in 30 adults with alopecia areata, a condition causing patchy or total hair loss. The drug is an IL-2 fusion protein given by injection. The main goal is to check safety and find the right dose for future studies, not to prov…
Phase: PHASE1 • Sponsor: HCW Biologics • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC